Results for: pharmaceutical+industry

Nasdaq ends up 9th session S&ampP 500, Dow dip with energy

How Jeb Bush's big bet on Florida economy may come back to haunt him

Texas governor woos disgruntled Conn. gun makers

Does France have right plan to revive its economy?

Japan PM's biggest test on economy still to come

AcelRx Pharma rises as analyst starts at "Buy"

India rejects Bayer plea against cheap cancer drug

BASF sees 2012 earns slip, raises dividend

Future science: Using 3D worlds to visualize data

Ahead of the Bell: Biogen shares keep climbing

US is halfway to Obama 5-year export-doubling goal

NJ tourism increased last year despite Sandy

Drugmakers, Interpol ramp up fight against fakes

New WVU center will do human trials for new drugs

Health care among early leaders in the S&P 500

Proposed East Coast uranium mine dividing Va.

FDA accepts application for new Sanofi MS drug

Penrice to pull the pin on soda ash production

FTC upholds decision against POM Wonderful

Monster shares fall under mounting pressure

Skechers, Lufkin, Penn Virginia are big movers

US companies are posting more jobs but filling few

Egypt to auction $1.3 billion for vital imports

Analysis - Darkest before dawn: Why some foreign investors are buying India

WADA to introduce new 'steroid passport'

Pfizer plans to shut down Sydney plant

Rhoen-Klinikum to sell hospitals to Fresenius for $4 billion

Analysis - Bribery scandal dents Big Pharma sales in China, GSK hardest hit

Rattled by investigations, foreign firms in China beef up compliance

Stocks held back by plunge in factory orders

Via surrogacy, some US men become single dads

Tenacious Aussie outsmarts cancer cells

Futures modestly higher ahead of Fed meeting

US stocks advance as stimulus concerns fade

Glaxo says China drugs sales slump on bribery probe

Pharmaceutical giant Teva announces departure of CEO

New cabinet threshold for drug listings

Novartis to cut more than 440 jobs in Britain

Tasmania not on a high about Top End poppy plan

Canada trade deficit narrows

AP IMPACT: Big Pharma cashes in on HGH abuse

Amgen to pay $762M settlement over drug marketing

Drug companies forge partnerships with top schools

Indian court to rule on generic drug industry

Race is on for EU's $1.3 billion science projects

DNC guests to party with donors, special interests

Stocks end mixed on weak US economic reports

Testosterone marketing frenzy draws skepticism

Concern among Tasmanian poppy growers over Victorian move to allow crops

Fluffy robot seals comfort dementia patients in nursing homes

Special Report - Lost hooves, dead cattle before Merck halted Zilmax sales

US stocks mostly lower ahead of Fed minutes

Southern councils back medicinal cannabis growing trials in Tasmania

Wall St. slips after two-day rally energy shares drop

Malaysia tries to parlay appeal to Muslim visitors into medical tourism...

Sanofi bets on inhaled insulin with MannKind deal

China car dealers cheer regulators’ drive to curb brands pricing power

Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets -...

Three Tasmanian councils push for industrial hemp and medicinal cannabis

China indicts GSK-linked foreign investigators: Xinhua